MedAssurant Inc., a Bowie, Md.-based provider of data-driven healthcare solutions, announced full implementation of its Quality Spectrum Cluster Logic (QSCL) technology, a proprietary analytical data structure designed to enable acceleration of complex healthcare data analyses. This powerful innovation has been shown to increase healthcare data analytical process runs by a factor of 2,000 over methodologies previously available.
Additionally, MedAssurant has integrated its Medical Outcomes Research for Effectiveness & Economics Registry (MORE2 Registry) dataset into the QSCL platform. The MORE2 Registry is a healthcare data asset comprised of more than 3.9 billion medical events from more than 76 million patients, 295,000 physicians and 185,000 clinical facilities throughout the United States. Through the power of these combined capabilities, MedAssurant can run highly sophisticated clinical analytics across billions of events within minutes – a process that would have previously required several weeks to complete.
Beyond accelerating analytics applied to client needs, the improved performance will further empower MedAssurant's product design, development and operational capabilities.
The availability of QSCL within MedAssurant's solution arsenal will immediately begin driving functional improvements within the company's Clinical & Quality Outcomes, Healthcare Data Insights, and Business Intelligence solutions. Full functionality enhancements will become effective within the next three months as the company's product enhancement cycle completes.
Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.